These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
90 related items for PubMed ID: 6831821
21. Dose-dependent suppression of norepinephrine appearance rate in plasma by clonidine in man. Veith RC, Best JD, Halter JB. J Clin Endocrinol Metab; 1984 Jul; 59(1):151-5. PubMed ID: 6725520 [Abstract] [Full Text] [Related]
22. Cardiovascular effects of desipramine in children and adults during exercise testing. Waslick BD, Walsh BT, Greenhill LL, Giardina EG, Sloan RP, Bigger JT, Bilich K. J Am Acad Child Adolesc Psychiatry; 1999 Feb; 38(2):179-86. PubMed ID: 9951217 [Abstract] [Full Text] [Related]
23. Assessment of noradrenergic functioning in patients with non-combat-related posttraumatic stress disorder: a study with desmethylimipramine and orthostatic challenges. Yatham LN, Sacamano J, Kusumakar V. Psychiatry Res; 1996 Jun 26; 63(1):1-6. PubMed ID: 8832768 [Abstract] [Full Text] [Related]
24. Central sympathoinhibition and peripheral neuronal uptake blockade after desipramine in rabbits. Eisenhofer G, Saigusa T, Esler MD, Cox HS, Angus JA, Dorward PK. Am J Physiol; 1991 Apr 26; 260(4 Pt 2):R824-32. PubMed ID: 1672797 [Abstract] [Full Text] [Related]
25. The effect of clorgyline on noradrenergic function. Ross RJ, Scheinin M, Lesieur P, Rudorfer MV, Hauger RL, Siever LJ, Linnoila M, Potter WZ. Psychopharmacology (Berl); 1985 Apr 26; 85(2):227-30. PubMed ID: 3925487 [Abstract] [Full Text] [Related]
26. Human galanin reduces plasma norepinephrine levels in man. degli Uberti EC, Ambrosio MR, Bondanelli M, Trasforini G, Margutti A, Valentini A, Rossi R, Franceschetti P. J Clin Endocrinol Metab; 1995 Jun 26; 80(6):1894-8. PubMed ID: 7539818 [Abstract] [Full Text] [Related]
27. An acute dose of desmethylimipramine inhibits brain uptake of [125I]3,3',5-triiodothyronine (T3) in thyroxine-induced but not T3-induced hyperthyroid rats: implications for tricyclic antidepressant therapy. Gordon JT, Tomlinson EE, Greenberg J, Dratman MB. J Pharmacol Exp Ther; 1994 Jul 26; 270(1):111-7. PubMed ID: 8035306 [Abstract] [Full Text] [Related]
28. The effects of desmethylimipramine on cognitive function in healthy subjects. Ross RJ, Smallberg S, Weingartner H. Psychiatry Res; 1984 May 26; 12(1):89-97. PubMed ID: 6589660 [Abstract] [Full Text] [Related]
29. Effects of S-adenosyl-methionine on plasma norepinephrine, blood pressure, and heart rate in healthy volunteers. Sherer MA, Cantoni GL, Golden RN, Rudorfer MV, Potter WZ. Psychiatry Res; 1986 Feb 26; 17(2):111-8. PubMed ID: 3961029 [Abstract] [Full Text] [Related]
30. Blood pressure and plasma norepinephrine concentrations after endogenous norepinephrine release by tyramine. Scriven AJ, Dollery CT, Murphy MB, Macquin I, Brown MJ. Clin Pharmacol Ther; 1983 Jun 26; 33(6):710-6. PubMed ID: 6851403 [Abstract] [Full Text] [Related]
31. Acute cardiovascular effects of tranylcypromine: correlation with plasma drug, metabolite, norepinephrine, and MHPG levels. Keck PE, Carter WP, Nierenberg AA, Cooper TB, Potter WZ, Rothschild AJ. J Clin Psychiatry; 1991 Jun 26; 52(6):250-4. PubMed ID: 2055897 [Abstract] [Full Text] [Related]
32. Role of the sympathetic nervous system in blood pressure maintenance in obesity. Sowers JR, Whitfield LA, Catania RA, Stern N, Tuck ML, Dornfeld L, Maxwell M. J Clin Endocrinol Metab; 1982 Jun 26; 54(6):1181-6. PubMed ID: 7042733 [Abstract] [Full Text] [Related]
33. [Effect of changing position from supine to standing upright on the circulation of young men and women]. Choe MA, Kim JI, Kim HL. Kanho Hakhoe Chi; 1989 Dec 26; 19(3):285-98. PubMed ID: 2625838 [Abstract] [Full Text] [Related]
34. Effect of diclofensine, a novel antidepressant, on peripheral adrenergic function. Gasić S, Korn A, Eichler HG. Clin Pharmacol Ther; 1986 May 26; 39(5):582-5. PubMed ID: 3698467 [Abstract] [Full Text] [Related]
35. Duloxetine increases serotonin and norepinephrine availability in healthy subjects: a double-blind, controlled study. Chalon SA, Granier LA, Vandenhende FR, Bieck PR, Bymaster FP, Joliat MJ, Hirth C, Potter WZ. Neuropsychopharmacology; 2003 Sep 26; 28(9):1685-93. PubMed ID: 12784100 [Abstract] [Full Text] [Related]
36. Neurotrophin-3- and norepinephrine-mediated adrenergic differentiation and the inhibitory action of desipramine and cocaine. Zhang JM, Dix J, Langtimm-Sedlak CJ, Trusk T, Schroeder B, Hoffmann R, Strosberg AD, Winslow JW, Sieber-Blum M. J Neurobiol; 1997 Mar 26; 32(3):262-80. PubMed ID: 9058320 [Abstract] [Full Text] [Related]
37. Norepinephrine content of various rat organs after chronic administration of desmethylimipramine. Avni J, Gerson S, Draskoczy PR, Schildkraut JJ. Arch Int Pharmacodyn Ther; 1975 Nov 26; 218(1):106-9. PubMed ID: 1212010 [Abstract] [Full Text] [Related]
38. Dose-dependent response to phenylpropanolamine: inhibition of orthostasis. Lake CR, Rosenberg DB, Gallant S, Zaloga G, Chernow B. J Clin Pharmacol; 1991 Jul 26; 31(7):624-35. PubMed ID: 1894758 [Abstract] [Full Text] [Related]
40. Effects of long-term desipramine administration on noradrenergic neurotransmission: electrophysiological studies in the rat brain. Lacroix D, Blier P, Curet O, de Montigny C. J Pharmacol Exp Ther; 1991 Jun 26; 257(3):1081-90. PubMed ID: 1646320 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]